Rosenblatt analyst Blair Abernethy downgraded Synopsys (SNPS) to Neutral from Buy with a price target of $605, down from $650.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys price target lowered to $550 from $650 at Stifel
- Synopsys price target lowered to $630 from $660 at Piper Sandler
- Synopsys double downgraded to Underperform at BofA on Intel, China overhangs
- Synopsys price target lowered to $550 from $630 at Wells Fargo
- Synopsys: Navigating Challenges with Optimism and Growth Potential